Integrating tuberculosis treatment into community pharmacies to improve TB/HIV outcomes in Uganda
The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).
Funding Fogarty Program
Emerging Global Leader
Project Information in NIH RePORTER
Integrating tuberculosis treatment into community pharmacies to improve TB/HIV outcomes in Uganda
Principal Institution
Infectious Diseases Institute
Principal Investigator(s) (PI)
Izudi, Jonathan
Project Contact Information
Email:
jonahzd@gmail.com
Year(s) Awarded
2024-2029
Country
Uganda
Project Description
An estimated three in 10 people with tuberculosis (TB)/HIV in sub-Saharan Africa have a suboptimal TB treatment outcome despite receiving effective anti-TB and antiretroviral therapy (ART) regimens. Monthly health facility visits to collect anti-TB drugs and ART refills present several challenges due to both direct and indirect costs, resulting in poor health care access, continuity of care, and treatment adherence.
These studies will evaluate whether integrating TB treatment into community pharmacies (a well-established differentiated ART delivery model) can improve access to both anti-TB drugs and ART refills and enhance TB/HIV treatment outcomes, hence contributing to the WHO;s End TB Strategy goals (zero TB deaths, zero TB infection, and zero catastrophic costs) and the UNAIDS target of less than 95% viral load suppression among people living with HIV.
Related World Regions / Countries
Related Global Health Research Topics